ZJJF(SH:600668)2016-10-30 16:00Financial Performance - Net profit attributable to shareholders of the listed company was ¥168,959,970.43, representing a growth of 24.42% year-on-year[7]. - Operating income for the period was ¥1,657,954,034.26, reflecting a 2.44% increase compared to the same period last year[7]. - Basic earnings per share rose to ¥0.49, up 24.42% from ¥0.39 in the previous year[7]. - The weighted average return on net assets increased by 0.93 percentage points to 7.55%[7]. - Total revenue for Q3 2016 was CNY 555,125,567.60, a slight decrease of 0.8% compared to CNY 559,571,895.76 in Q3 2015[24]. - Net profit for the first nine months of 2016 reached CNY 1,657,954,034.26, an increase of 2.4% compared to CNY 1,618,447,058.99 in the previous year[24]. - Net profit attributable to the parent company reached 65,328,991.80 CNY, up from 44,011,681.91 CNY year-over-year, indicating a growth of about 48%[25]. - The total comprehensive income for Q3 2016 was 87,696,000.95 CNY, compared to 49,274,697.67 CNY in the previous year, reflecting a significant increase of approximately 78%[26]. - The total profit for the first nine months of 2016 was 126,158,015.36 CNY, compared to 94,680,574.90 CNY in the previous year, representing an increase of approximately 33%[28]. Cash Flow - Cash flow from operating activities generated ¥190,735,047.87, a significant recovery from a negative cash flow of ¥33,539,265.08 in the same period last year[7]. - Cash inflow from operating activities totaled CNY 1,963,430,981.93, an increase from CNY 1,773,762,616.57 year-on-year[32]. - Cash outflow from operating activities was CNY 1,772,695,934.06, down from CNY 1,807,301,881.65 in the previous year[32]. - Net cash flow from operating activities for the first nine months was CNY 190,735,047.87, compared to a negative CNY 33,539,265.08 in the previous year[32]. - The company reported a significant increase in cash received from operating activities, with CNY 201,573,491.72 received from other operating activities compared to CNY 549,185.01 last year[35]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥3,652,378,994.82, an increase of 0.58% compared to the end of the previous year[7]. - The company’s total assets increased slightly from CNY 3,631,482,179.27 to CNY 3,652,378,994.82, reflecting a stable asset base[19]. - Total liabilities decreased to CNY 780,775,403.83 from CNY 825,740,837.89 at the start of the year, reflecting a reduction of approximately 5.4%[23]. - The company’s accounts payable increased by 13.56% from CNY 299,562,347.01 to CNY 340,180,820.16, indicating higher operational liabilities[19]. - The company’s cash and cash equivalents decreased from CNY 149,368,328.32 to CNY 109,249,127.95, reflecting a reduction in liquidity[18]. - The company’s non-current assets decreased slightly from CNY 2,859,055,386.93 to CNY 2,842,693,076.21, indicating a stable long-term asset position[19]. Shareholder Information - The total number of shareholders reached 23,849 at the end of the reporting period[10]. - The largest shareholder, Jinhua Tongji State-owned Assets Investment Co., Ltd., holds 55,564,103 shares, accounting for 16.15% of the total shares[10]. Operational Changes - The company reported a total of ¥4,158,066.15 in non-recurring gains and losses for the current period[9]. - The company reported a 67.67% decrease in non-operating income, dropping from CNY 55,007,073.71 to CNY 17,785,492.10, mainly due to asset disposals in the previous year[12]. - The company established a joint venture with German company Gevepharm and Zhuhai Hengqin Deyun Jia International Trade Co., Ltd. to create a pharmaceutical enterprise focused on pediatric medications in Jinhua, Zhejiang[13]. - The company has not disclosed any new product developments or market expansion strategies in this report[6]. - The company plans to continue focusing on market expansion and new product development to drive future growth[24]. Investment and Financial Expenses - The company reported an investment income of 27,516,738.23 CNY from joint ventures and associates, a decrease from 57,913,316.93 CNY in the previous year, indicating a decline of approximately 52%[28]. - The company incurred income tax expenses of 13,066,105.27 CNY, up from 12,892,214.68 CNY in the previous year, reflecting a rise of about 1.4%[25]. - The company reported a significant reduction in financial expenses, with a net financial cost of 298,772.51 CNY compared to a gain of 2,174,889.48 CNY in the previous year[28].